Recent Updates
Recently added Catalysts
UTHR Positive Sentiment

United Therapeutics Expands Organ Manufacturing Capabilities with Opening of Third Designated Pathogen-Free Xenograft Production Facility

Tuesday, October 20, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: United Therapeutics Corporation has announced the opening of its third Designated Pathogen-Free (DPF) facility in Houston, Texas. This new facility, named after Dr. Bartley P. Griffith and Dr. Robert A. Montgomery, aims to enhance the company's organ manufacturing capabilities. The first DPF facility was established in Christiansburg, Virginia, in 2024 to support clinical trials.

Market Sentiment Analysis

POSITIVE FACTORS

  • Opening of a new production facility in Houston, Texas.
  • Expansion of organ manufacturing capabilities.
  • Support for ongoing clinical trials with xenografts.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+83%
120-day peak, hindsight
Typical move
6.5%
average across 6 past catalysts
Lead asset
APD811
NDA/BLA · Pulmonary Arterial Hypertension

Full Press Release Details

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the opening of its third Designated Pathogen-Free (DPF) facility, The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility, in Houston, Texas. United Therapeutics opened its first DPF facility in Christiansburg, Va. in 2024 to produce xenografts for ongoing clinical trials. The company celebrated the openi

Frequently Asked Questions

What is the purpose of the new DPF facility?

The new DPF facility aims to enhance organ manufacturing capabilities for clinical trials.

Where is the new xenograft production facility located?

The new facility is located in Houston, Texas.

When was the first DPF facility opened?

The first DPF facility was opened in Christiansburg, Virginia, in 2024.

Who are the namesakes of the new facility?

The facility is named after Dr. Bartley P. Griffith and Dr. Robert A. Montgomery.

ShareAdd on Google
Tags: UTHR United Therapeutics xenograft organ manufacturing Houston clinical trials
Last updated: Oct 20, 2026

Biotech snapshot

Cash runway
$3803M liquidity · $0M/mo burn
Low dilution risk
Lead asset
APD811NDA/BLA
Pulmonary Arterial Hypertension →

Catalyst track record

+83%
best trade around UTHR's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for UTHR.

See every catalyst's timing & PoA →